CN Patent
CN105377341B — 药物输送装置
Assigned to Sanofi Aventis France · Expires 2020-08-04 · 6y expired
What this patent protects
本发明涉及用于选择和分配若干用户可变剂量的药剂的药物输送装置。该器件包括用于在剂量选择期间生成触觉和/或听觉反馈的至少一个卡嗒发声器机构(52,64;143,153),其中卡嗒发声器机构(143,153)在选择单个单位或者单个单位的倍数时产生不同反馈。
USPTO Abstract
本发明涉及用于选择和分配若干用户可变剂量的药剂的药物输送装置。该器件包括用于在剂量选择期间生成触觉和/或听觉反馈的至少一个卡嗒发声器机构(52,64;143,153),其中卡嗒发声器机构(143,153)在选择单个单位或者单个单位的倍数时产生不同反馈。
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.